AFFINITY MOLECULES LLC

Richmond, VA · Biotech · Private

Immobilized enzyme pipeline for cost-effective mRNA production through reusable RNA polymerases and modification enzymes

affymol.com →
Grants
$594K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Large scale in vitro production of capped polyadenylated mRNA-based vaccines in solid phase using immobilized enzymes$297,193
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Large scale in vitro production of capped polyadenylated mRNA-based vaccines in solid phase using immobilized enzymes$297,193
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2667Scudo Biosciences Inc—$50K
2668Orna Therapeutics——
2669ePurines, Inc.—$50K
2670AFFINITY MOLECULES LLC——
2671Paralos Bioscience Inc.—$50K
2672POTOMAC AFFINITY PROTEIN LLC——
2673Advanced Gene Transfer Company, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.